Michael A. Cannarile
Penzberg, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
First-in-human phase 1 study of RO7119929, an oral TLR7 agonist prodrug, in patients with advanced primary or metastatic liver cancers.
Journal: Journal for immunotherapy of cancer
Published: February 09, 2026
Tumor-agnostic transcriptome-based classifier identifies spatial infiltration patterns of CD8+T cells in the tumor microenvironment and predicts clinical outcome in early-phase and late-phase clinical trials.
Journal: Journal for immunotherapy of cancer
Published: March 18, 2024
Molecular subtypes of hepatocellular carcinoma linked to liver cell lineages and clinical outcomes of combination immunotherapy.
Journal: Cell reports. Medicine
Published: July 06, 2023
Facts and Hopes on Biomarkers for Successful Early Clinical Immunotherapy Trials: Innovative Patient Enrichment Strategies.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 20, 2023
Anti-CSF-1R emactuzumab in combination with anti-PD-L1 atezolizumab in advanced solid tumor patients naïve or experienced for immune checkpoint blockade.
Journal: Journal for immunotherapy of cancer
Published: March 08, 2022
Immune contexture of paediatric cancers.
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 01, 2022
Biomarker Technologies to Support Early Clinical Immuno-oncology Development: Advances and Interpretation.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 24, 2020
Society for Immunotherapy of Cancer clinical and biomarkers data sharing resource document: Volume II-practical challenges.
Journal: Journal for immunotherapy of cancer
Published: October 06, 2020
Phase Ib study of anti-CSF-1R antibody emactuzumab in combination with CD40 agonist selicrelumab in advanced solid tumor patients.
Journal: Journal for immunotherapy of cancer
Published: September 21, 2020
Society for Immunotherapy of Cancer clinical and biomarkers data sharing resource document: Volume I-conceptual challenges.
Journal: Journal for immunotherapy of cancer
Published: August 31, 2020
Macrophage depletion induces edema through release of matrix-degrading proteases and proteoglycan deposition.
Journal: Science translational medicine
Published: June 22, 2020
Long-term clinical activity, safety and patient-reported quality of life for emactuzumab-treated patients with diffuse-type tenosynovial giant-cell tumour.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 29, 2020
Last Updated: 09/26/2026